Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Prognostic Value of a Classification System for Iliofemoral Stenting in Patients With Chronic Venous Obstruction Publisher Pubmed

Summary: Can vein stents last? Study classifies CVO types—patency drops from 95% to 39% by severity. Suggests better outcome predictions. #VascularHealth #StentTherapy

Jalaie H1 ; Barbati ME1 ; Piao L1, 2 ; Doganci S3 ; Kucher N4 ; Dumantepe M5 ; Hartung O6 ; Lichtenberg M7 ; Black S8 ; Osullivan G9, 17 ; Avgerinos ED10 ; Davies AH11 ; Razavi MK12 ; Toonder IM13 Show All Authors
Authors
  1. Jalaie H1
  2. Barbati ME1
  3. Piao L1, 2
  4. Doganci S3
  5. Kucher N4
  6. Dumantepe M5
  7. Hartung O6
  8. Lichtenberg M7
  9. Black S8
  10. Osullivan G9, 17
  11. Avgerinos ED10
  12. Davies AH11
  13. Razavi MK12
  14. Toonder IM13
  15. Sebastian T4
  16. Erbel C14
  17. Moini M15
  18. De Graaf R16
  19. Morris RI8
  20. Omalley E9, 17
  21. Chaer RA18

Source: European Journal of Vascular and Endovascular Surgery Published:2025


Abstract

Objective: This retrospective, multicentre study aimed to assess the prognostic value of a proposed classification system for chronic venous obstruction (CVO) patients undergoing successful interventional procedures. Methods: This study analysed data from 13 vascular centres, including 1 033 patients with CVO treated between 2015 – 2019. The patients were classified into five category types: 1 – non-thrombotic iliac vein lesion; 2 – CVO of iliac segment; 3 – CVO of iliofemoral segment above common femoral vein confluence; 4 – CVO of iliofemoral segment extending into the femoral vein (FV) or deep femoral vein (DFV); and 5 – CVO of iliofemoral segment involving both DFV and FV. Stent deployment, complications, and follow ups were evaluated. Uni- and multivariable analyses were performed to identify predictors of primary patency loss. Results: The mean age of the patients was 44.0 ± 14.7 years, with 59.9% being women. A median of two stents was used for unilateral cases and five stents for bilateral cases. At twelve months follow up, primary patency rates for types 1 – 5 were 94.9%, 90.3%, 80.8%, 60.6%, and 39.4%, respectively. These rates were strongly correlated with the extent of CVO and showed significant differences between each type. Univariable analysis identified predictors of primary patency loss as the type of CVO, history of deep vein thrombosis, and the total number of stents. In the multivariable analysis, the significant independent predictors of primary patency loss were the type of CVO and the total number of stents. Conclusion: The proposed anatomical classification of iliofemoral CVO will help to predict intervention outcomes and facilitate comparison of stent outcomes in future studies. However, further evaluation and validation in prospective studies are needed to confirm the utility of this classification. © 2024 The Author(s)
Other Related Docs